Analytical Relationships Among Biosite, Bayer, and Roche Methods for BNP and NT-proBNP

Autor:	Raymond E. Karcher, Valerie J. Peterson, Janice Eisenstadt, Elizabeth Sykes, John Gusway, Mamtha Balasubramaniam, David A. Tushman
Rok vydání:	2005
Předmět:	medicine.medical_specialty Amino-terminal pro-brain natriuretic peptide medicine.drug_class business.industry General Medicine Brain natriuretic peptide Endocrinology Internal medicine Natriuretic peptide medicine Cardiology N terminal pro b type natriuretic peptide business Serum creatinine level
Zdroj:	American Journal of Clinical Pathology. 123:584-590
ISSN:	1943-7722 0002-9173
DOI:	10.1309/f86fvefdgx06dtuv
Popis:	This study determined whether, for patient monitoring, it is feasible to convert B-type natriuretic peptide (BNP) results obtained using Triage (BNP, Biosite, San Diego, CA), Centaur (BNP, Bayer Diagnostics, Tarrytown, NY), and Elecsys 2010 (Nterminal proBNP; Roche, Indianapolis, IN) assays. Concordance between assays and effects of renal impairment also were assessed. Samples were primarily from emergency center patients. Biosite testing was performed immediately; Bayer and Roche testing was performed later on plasma stored frozen (–30°C). Logistic regression relationships were as follows: Bayer = 0.57 Biosite + 23.1, n = 121, R 2 = 0.85; Roche = 6.09 Biosite – 220.4 + 1,131.6 (if female), n = 131, R 2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3012916cb4df633e6a635ef3a7a61b9b https://doi.org/10.1309/f86fvefdgx06dtuv Zobrazit plný text záznamu